Symmetry Medical, Inc. (SMA) Tops Q2 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Wall Street ends higher as Fed holds key rate steady, focus turns to earnings
- SK Hynix shares surge after Q3 profit beats expectations
- Oil prices rise on Yemen fighting, Saudi refinery attack
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
Tweet
Share
E-mailGet Alerts SMA Hot Sheet
Join SI Premium – FREE
Symmetry Medical, Inc. (NYSE: SMA) reported Q2 EPS of $0.17, $0.05 better than the analyst estimate of $0.12. Revenue for the quarter came in at $101.3 million versus the consensus estimate of $99.17 million.
For earnings history and earnings-related data on Symmetry Medical, Inc. (SMA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Plexus Corp (PLXS) Tops Q4 EPS by 29c; offers guidance
- Algoma Steel Group (ASTL) Misses Q3 EPS by 49c
- ING Groep N.V. (ING) Misses Q3 EPS by 2c; offers outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
